Professor Peter Collins

Publications


Journals

  • Kotecha D; New G; Collins P; Eccleston D; Krum H; Pepper J; Flather MD. (4 Apr 2012). Radial artery pulse wave analysis for non-invasive assessment of coronary artery disease. Int J Cardiol. DOI.
  • Asbury E; Webb C; Probert H; Wright C; Barbir M; Fox K; Collins P. (22 Nov 2011). Cardiac Rehabilitation Improves Physical Functioning in Refractory Angina. CIRCULATION. 124. Author weblink.
  • Collins P; Vitale C; Spoletini I; Barbaro G. (1 Apr 2011). Gender Differences in the Clinical Presentation of Heart Disease. CURRENT PHARMACEUTICAL DESIGN. 17:1056-1058.
  • Webb CM; Collins P; Moat NE; Chong CF. (19 Apr 2011). Response to Letters Regarding Article, "Vascular Reactivity and Flow Characteristics of Radial Artery and Long Saphenous Vein Coronary Bypass Grafts: A 5-Year Follow-Up". CIRCULATION. 123:E414-E414. Author weblink DOI.
  • Asbury EA; Webb CM; Collins P. (Feb 2011). Group support to improve psychosocial well-being and primary-care demands among women with cardiac syndrome X. Climacteric. 14:100-104. DOI.
  • Wenger NK; Mischke JM; Schroeder R; Schroeder K; Collins P; Grady D; Kornitzer M; Mosca L; et alBarrett-Connor E. (1 Dec 2010). Electrocardiograms of Menopausal Women With Coronary Heart Disease or at Increased Risk for Its Occurrence. AMERICAN JOURNAL OF CARDIOLOGY. 106:1580-1587. Author weblink DOI.
  • Rosano GMC; Collins P. (1 Dec 2010). Gender differences in treatment of cardiovascular disease: a task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 24:662-663. DOI.
  • Rosano GM; Collins P. (Dec 2010). Gender differences in treatment of cardiovascular disease: a task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology. Fundam Clin Pharmacol. 24:662-663. DOI.
  • Iellamo F; Volterrani M; Caminiti G; Karam R; Massaro R; Fini M; Collins P; Rosano GMC. (12 Oct 2010). Testosterone Therapy in Women With Chronic Heart Failure A Pilot Double-Blind, Randomized, Placebo-Controlled Study. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 56:1310-1316. DOI.
  • Webb CM; Moat NE; Chong CF; Collins P. (31 Aug 2010). Vascular reactivity and flow characteristics of radial artery and long saphenous vein coronary bypass grafts: a 5-year follow-up. Circulation. 122:861-867. DOI.
  • Webb CM; Collins P. (Sep 2010). Testosterone and coronary artery disease in men. Maturitas. 67:15-19. DOI.
  • Collins P; Mosca L; Geiger MJ; Amewou-Atisso MG; Effron MB; Dowsett S; Grady D; Kornitzer M; et alBarrett-Connor E; Wenger NK. (27 Oct 2009). Response to Letter Regarding Article "Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in the Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors". CIRCULATION. 120:E148-E148. Author weblink DOI.
  • Daly C; Fitzgerald AR; O'Callaghan P; Collins P; Cooney MT; Graham IM. (1 Apr 2009). Homocysteine increases the risk associated with hyperlipidaemia. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION. 16:150-155. Author weblink DOI.
  • Collins P; Mosca L; Geiger MJ; Grady D; Kornitzer M; Amewou-Atisso MG; Effron MB; Dowsett SA; et alBarrett-Connor E; Wenger NK. (24 Feb 2009). Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial Results of Subgroup Analyses by Age and Other Factors. CIRCULATION. 119:922-930. Author weblink DOI.
  • Chong WCF; Collins P; Webb CM; De Souza AC; Pepper JR; Hayward CS; Moat NE. (1 Jan 2006). Comparison of flow characteristics and vascular reactivity of radial artery and long saphenous vein grafts [NCT00139399]. JOURNAL OF CARDIOTHORACIC SURGERY. 1. Author weblink DOI.
  • Asbury EA; Kanji N; Ernst E; Barbir M; Collins P. (1 Jan 2009). Autogenic training to manage symptomology in women with chest pain and normal coronary arteries. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. 16:60-65. Author weblink DOI.
  • Mosca L; Grady D; Barrett-Connor E; Collins P; Wenger N; Abramson BL; Paganini-Hill A; Geiger MJ; et alDowsett SA; Amewou-Atisso M; Kornitzer M. (1 Jan 2009). Effect of Raloxifene on Stroke and Venous Thromboembolism According to Subgroups in Postmenopausal Women at Increased Risk of Coronary Heart Disease. STROKE. 40:147-155. Author weblink DOI.
  • Swan L; Kraidly M; Vonder Muhll I; Collins P; Gatzoulis MA. (18 Mar 2010). Surveillance of cardiovascular risk in the normotensive patient with repaired aortic coarctation. Int J Cardiol. 139:283-288. DOI.
  • Vitale C; Collins P. (1 Sep 2008). Optimization of Cardiac Metabolism in Diabetes Mellitus. CURRENT PHARMACEUTICAL DESIGN. 14:2537-2550. Author weblink DOI.
  • Webb CM; Hayward CS; Mason MJ; Ilsley CD; Collins P. (Dec 2008). Coronary vasomotor and blood flow responses to isoflavone-intact soya protein in subjects with coronary heart disease or risk factors for coronary heart disease. Clin Sci (Lond). 115:353-359. DOI.
  • Figtree GA; Grieve SM; Speller B; Geiger M-J; Robinson BG; Channon KM; Ragoussis J; Collins P; et alWatkins H. (1 Aug 2008). A commonly occurring polymorphism upstream of the estrogen receptor alpha alters transcription and is associated with increased HDL. ATHEROSCLEROSIS. 199:354-361. Author weblink DOI.
  • Grady D; Cauley JA; Geiger MJ; Kornitzer M; Mosca L; Collins P; Wenger NK; Song J; et alMershon J; Barrett-Connor E. (18 Jun 2008). Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. JOURNAL OF THE NATIONAL CANCER INSTITUTE. 100:854-861. Author weblink DOI.
  • Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; et alPalacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M. (1 Nov 2007). Management of cardiovascular risk in the peri-menopausal woman - a consensus statement of European cardiologists and gynaecologists. KARDIOLOGIA POLSKA. 65:1331-1349. Author weblink.
  • Asbury EA; Slattery C; Grant A; Evans L; Barbir M; Collins P. (1 May 2008). Cardiac rehabilitation for the treatment of women with chest pain and normal coronary arteries. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. 15:454-460. Author weblink DOI.
  • Collins P; Webb CM; Chong CF; Moat NE; Radial Artery Versus Saphenous Vein Patency (RSVP) Trial Investigators. (3 Jun 2008). Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation. 117:2859-2864. DOI.
  • Ullrich ND; Krust A; Collins P; MacLeod KT. (Jun 2008). Genomic deletion of estrogen receptors ERalpha and ERbeta does not alter estrogen-mediated inhibition of Ca2+ influx and contraction in murine cardiomyocytes. Am J Physiol Heart Circ Physiol. 294:H2421-H2427. DOI.
  • Webb CM; Elkington AG; Kraidly MM; Keenan N; Pennell DJ; Collins P. (1 Mar 2008). Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease. Am J Cardiol. 101:618-624. DOI.
  • Mirza FS; Ong P; Collins P; Okamura K; Gerhard-Herman M; Williams GH; Seely EW. (1 Jan 2008). Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. 15:44-50. Author weblink DOI.
  • Vitale C; Mercuro G; Cerquetani E; Marazzi G; Patrizi R; Pelliccia F; Volterrani M; Fini M; et alCollins P; Rosano GM. (Feb 2008). Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol. 28:348-352. DOI.
  • Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; et alPalacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M. (Dec 2007). Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists. Climacteric. 10:508-526. DOI.
  • Collins P. (14 Mar 2008). HDL-C in post-menopausal women: An important therapeutic target. Int J Cardiol. 124:275-282. DOI.
  • Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; et alPalacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M. (1 Aug 2007). Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. EUROPEAN HEART JOURNAL. 28:2028-2040. Author weblink DOI.
  • Chikwe J; Athanasiou T; Collins P; Pepper JR. (1 May 2007). Safety and efficacy concerns regarding elective coronary artery surgery in patients with prior coronary stents. EUROPEAN HEART JOURNAL. 28:1265-1265. DOI.
  • Bugiardini R; Badimon L; Collins P; Erbel R; Fox K; Hamm C; Pinto F; Rosengren A; et alStefanadis C; Wallentin L; de Werf FV. (1 Feb 2007). Angina, "normal" coronary angiography, and vascular dysfunction: Risk assessment strategies. PLOS MEDICINE. 4:252-255. Author weblink DOI.
  • Sorensen MB; Franks S; Robertson C; Pennell DJ; Collins P. (Nov 2006). Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors. Clin Endocrinol (Oxf). 65:655-659. DOI.
  • Collins P; Flather M; Lees B; Mister R; Proudler AJ; Stevenson JC; WHISP (Women's Hormone Intervention Secondary Prevention Study) Pilot Study Investigators. (Sep 2006). Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study. Eur Heart J. 27:2046-2053. DOI.
  • Barrett-Connor E; Mosca L; Collins P; Geiger MJ; Grady D; Kornitzer M; McNabb MA; Wenger NK. (13 Jul 2006). Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. NEW ENGLAND JOURNAL OF MEDICINE. 355:125-137. Author weblink DOI.
  • Asbury EA; Chandrruangphen P; Collins P. (Jul 2006). The importance of continued exercise participation in quality of life and psychological well-being in previously inactive postmenopausal women: a pilot study. Menopause. 13:561-567. DOI.
  • Collins P. (1 May 2006). Risk factors for cardiovascular disease and hormone therapy in women. HEART. 92:24-28. Author weblink DOI.
  • Liew R; Stagg MA; MacLeod KT; Collins P. (5 Sep 2005). The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes. Eur J Pharmacol. 519:1-8. DOI.
  • Asbury EA; Collins P. (Sep 2005). Cardiac syndrome X. Int J Clin Pract. 59:1063-1069. DOI.
  • Webb CM; Collins P; Di Mario C. (1 Feb 2005). Normal coronary physiology assessed by intracoronary Doppler ultrasound. HERZ. 30:8-16. Author weblink DOI.
  • Asbury EA; Collins P. (Feb 2005). Psychosocial factors associated with noncardiac chest pain and cardiac syndrome X. Herz. 30:55-60. DOI.
  • Asbury EA; Creed F; Collins P. (Oct 2004). Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X. Eur Heart J. 25:1695-1701. DOI.
  • Chong CF; Ong PJ; Moat N; Collins P. (Oct 2004). Effects of hydrostatic distention on in vitro vasoreactivity of radial artery conduits. J Thorac Cardiovasc Surg. 128:609-614. DOI.
  • Liew R; Stagg MA; MacLeod KT; Collins P. (May 2004). Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the L-type calcium current. Br J Pharmacol. 142:89-96. DOI.
  • Waters DD; Gordon D; Rossouw JE; Cannon RO; Collins P; Herrington DM; Hsia J; Langer R; et alMosca L; Ouyang P; Sopko G; Stefanick ML; National Heart, Lung and Blood Institute; American College of Cardiology Foundation. (17 Feb 2004). Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials. Circulation. 109:e53-e55. DOI.
  • Liew R; Stagg MA; MacLeod KT; Collins P. (26 Jan 2004). Acute actions of 3 alpha-hydroxy-tibolone on factors influencing contraction in guinea-pig ventricular myocytes. Eur J Pharmacol. 484:141-145.
  • Khan NE; De Souza A; Mister R; Flather M; Clague J; Davies S; Collins P; Wang D; et alSigwart U; Pepper J. (1 Jan 2004). A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med. 350:21-28. DOI.
  • Liew R; Stagg MA; Chan J; Collins P; MacLeod KT. (1 Jan 2004). Gender determines the acute actions of genistein on intracellular calcium regulation in the guinea-pig heart. Cardiovasc Res. 61:66-76.
  • Liew R; Macleod KT; Collins P. (Jul 2003). Novel stimulatory actions of the phytoestrogen genistein: effects on the gain of cardiac excitation-contraction coupling. FASEB J. 17:1307-1309. DOI.
  • Sorensen MB; Collins P; Ong PJL; Webb CM; Hayward CS; Asbury EA; Gatehouse PD; Elkington AG; et alYang GZ; Kubba A; Pennell DJ. (27 May 2003). Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance - Response. CIRCULATION. 107:E197-E197. Author weblink.
  • Chong WC; Ong PJ; Hayward CS; Collins P; Moat NE. (Apr 2003). Effects of radial artery harvesting on forearm function and blood flow. Ann Thorac Surg. 75:1171-1174.
  • Sorensen MB; Collins P; Ong PJL; Webb CM; Hayward CS; Asbury EA; Gatehouse PD; Elkington AG; et alYang GZ; Kubba A; Pennell DJ. (11 Mar 2003). Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance - Response. CIRCULATION. 107:E67-E68. Author weblink.
  • Liew R; Williams JK; Collins P; MacLeod KT. (Mar 2003). Soy-derived isoflavones exert opposing actions on Guinea pig ventricular myocytes. J Pharmacol Exp Ther. 304:985-993. DOI.
  • Sorensen MB; Collins P; Ong PJ; Webb CM; Hayward CS; Asbury EA; Gatehouse PD; Elkington AG; et alYang GZ; Kubba A; Pennell DJ. (24 Sep 2002). Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation. 106:1646-1651.
  • Collins P. (3 Jul 2002). Clinical cardiovascular studies of hormone replacement therapy. Am J Cardiol. 90:30F-34F.
  • Ong PJ; Webb CM; Sorensen MB; Hayward CS; Collins P. (Jul 2002). A comparison of brachial artery reactivity measured by external and intravascular ultrasound. Ultrasound Med Biol. 28:911-916.
  • Grothues F; Smith GC; Moon JC; Bellenger NG; Collins P; Klein HU; Pennell DJ. (1 Jul 2002). Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 90:29-34.
  • Chandrruangphen P; Collins P. (1 Jul 2002). Exercise-induced suppression of postprandial lipemia: A possible mechanism of endothelial protection?. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 22:1239-1239. Author weblink DOI.
  • Panting JR; Gatehouse PD; Yang GZ; Grothues F; Firmin DN; Collins P; Pennell DJ. (20 Jun 2002). Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 346:1948-1953. DOI.
  • Hayward CS; Kraidly M; Webb CM; Collins P. (2002). Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol. 40:521-528.
  • Wenger NK; Barrett-Connor E; Collins P; Grady D; Kornitzer M; Mosca L; Sashegyi A; Bayghani SK; et alAnderson PW; Moscarelli E. (2002). Baseline characteristics of participants in the Raloxifene use for the heart (RUTH) trial. Am J Cardiol. 90:1204-1210.
  • Collins P; Stevenson JC. (2002). Spotlight on gender. Cardiovasc Res. 3, 53:535-537.
  • Pennell DJ; Panting JR; Collins P. (2002). Syndrome X and cardiovascular magnetic resonance (letter). N Engl J Med. 347:1378.
  • Ong PJ; Linardou H; Graham HA; Savage P; Hayward CS; Coombes RC; Collins P. (Oct 2001). Tamoxifen is not detrimental to endothelial function in postmenopausal women with breast cancer. Am Heart J. 142:E6. DOI.
  • Chong WC; Ong PJ; Hayward C; Moat N; Collins P. (Sep 2001). Effects of storage solutions on in vitro vasoreactivity of radial artery conduits. J Thorac Cardiovasc Surg. 122:470-475. DOI.
  • Mosca L; Barrett-Connor E; Wenger NK; Collins P; Grady D; Kornitzer M; Moscarelli E; Paul S; et alWright TJ; Helterbrand JD; Anderson PW. (15 Aug 2001). Design and methods of the Raloxifene Use for The Heart (RUTH) study. Am J Cardiol. 88:392-395.
  • Mosca L; Collins P; Herrington DM; Mendelsohn ME; Pasternak RC; Robertson RM; Schenck-Gustafsson K; Smith SC; et alTaubert KA; Wenger NK; American Heart Association. (24 Jul 2001). Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 104:499-503.
  • Adamson DL; Webb CM; Collins P. (Jul 2001). Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. Menopause. 8:233-238.
  • Hayward CS; Webb CM; Collins P. (28 Apr 2001). Effect of sex hormones on cardiac mass. Lancet. 357:1354-1356. DOI.
  • Collins P. (28 Feb 2001). Vascular effects of hormones. Maturitas. 38:45-50.
  • Grothues F; Smith GS; Bellenger NG; Collins P; Klein HU; Pennell DJ. (1 Feb 2001). Comparison of interstudy reproducibility of Cardiovascular Magnetic Resonance and 2D-Echocardiography in a mixed study group and implications for clinical trial planning. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 37:392A-392A. Author weblink.
  • Stevenson JC; Flather M; Collins P. (21 Dec 2000). Coronary heart disease in women. NEW ENGLAND JOURNAL OF MEDICINE. 343:1891-1891. Author weblink.
  • Rosano GMC; Webb CM; Chierchia S; Morgani GL; Gabraele M; Sarrel PM; de Ziegler D; Collins P. (1 Dec 2000). Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 36:2154-2159. Author weblink DOI.
  • Figtree GA; Webb CM; Collins P. (Nov 2000). Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism. J Pharmacol Exp Ther. 295:519-523.
  • Webb CM; Ghatei MA; McNeill JG; Collins P. (3 Oct 2000). 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation. 102:1617-1622.
  • Sorensen M; Ong P; Webb C; Hayward C; Gatehouse P; Collins P; Pennell D. (1 Jun 2000). Measurement of endothelium-dependent and endothelium-independent vascular function by cardiovascular magnetic resonance. JOURNAL OF PHYSIOLOGY-LONDON. 525:11P-11P. Author weblink.
  • Figtree GA; Griffiths H; Lu YQ; Webb CM; MacLeod K; Collins P. (Jun 2000). Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J Am Coll Cardiol. 35:1977-1985.
  • Hayward CS; Kelly RP; Collins P. (Apr 2000). The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res. 46:28-49.
  • Ong PJ; Patrizi G; Chong WC; Webb CM; Hayward CS; Collins P. (15 Jan 2000). Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol. 85:269-272.
  • Ong PJL; Dean TS; Hayward CS; Della Monica PL; Sanders TAB; Collins P. (18 Dec 1999). Effect of fat and carbohydrate consumption on endothelial function. LANCET. 354:2134-2134. Author weblink DOI.
  • Soresen MB; Ong PJ; Hayward CS; Webb CM; Gatehouse PD; Collins P; Pennell DJ. (2 Nov 1999). Gradient echo magnetic resonance imaging of the brachial artery: A novel method far assessing vascular reactivity. CIRCULATION. 100:49-49. Author weblink.
  • Webb CM; McNeill JG; Hayward CS; de Zeigler D; Collins P. (19 Oct 1999). Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 100:1690-1696.
  • Figtree GA; Lu Y; Webb CM; Collins P. (7 Sep 1999). Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. Circulation. 100:1095-1101.
  • Schulze-Neick I; Penny DJ; Rigby ML; Morgan C; Kelleher A; Collins P; Li J; Bush A; et alShinebourne EA; Redington AN. (17 Aug 1999). L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery. Circulation. 100:749-755.
  • Hayward CS; Webb CM; Collins P. (17 Jul 1999). Hormone replacement therapy and heart-rate variability. LANCET. 354:256-256. Author weblink DOI.
  • Webb CM; Adamson DL; de Zeigler D; Collins P. (1 Feb 1999). Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol. 83:437-A9.
  • Barrett-Connor E; Wenger NK; Grady D; Mosca L; Collins P; Kornitzer M; Cox DA; Moscarelli E; et alAnderson PW. (30 Nov 1998). Coronary heart disease in women: Randomized clinical trials, HERS and RUTH. MATURITAS. 31:1-7. Author weblink.
  • Schulze-Neick I; Penny DJ; Rigby ML; Morgan C; Li J; Collins P; Shinebourne EA; Redington AN. (27 Oct 1998). L-arginine and substance p reverse the pulmonary endothelial dysfunction after congenital heart surgery. CIRCULATION. 98:547-547. Author weblink.
  • Brookes CI; White PA; Staples M; Oldershaw PJ; Redington AN; Collins PD; Noble MI. (27 Oct 1998). Myocardial contractility is not constant during spontaneous atrial fibrillation in patients. Circulation. 98:1762-1768.
  • Barrett-Connor E; Wenger NK; Grady D; Mosca L; Collins P; Kornitzer M; Cox DA; Moscarelli E; et alAnderson PW. (1 Sep 1998). Hormone and nonhormone therapy for the maintenance of postmenopausal health: The need for randomized controlled trials of estrogen and raloxifene. JOURNAL OF WOMENS HEALTH. 7:839-847. Author weblink DOI.
  • Webb CM; Rosano GMC; Collins P. (23 May 1998). Oestrogen improves exercise-induced myocardial ischaemia in women. LANCET. 351:1556-1557. Author weblink DOI.
  • Webb CM; McNeill JG; Collins P. (1 Feb 1998). Testosterone increases coronary blood flow in men with coronary artery disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 31:2A-2A. Author weblink DOI.
  • Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P. (Jan 1998). The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study. Eur J Cardiothorac Surg. 13:42-48.
  • Rosano GMC; Caixeta AM; Chierchia S; Arie S; LopezHidalgo M; Pereira WI; Leonardo F; Webb CM; et alPileggi F; Collins P. (4 Nov 1997). Short-term anti-ischemic effect of 17 beta-estradiol in postmenopausal women with coronary artery disease. CIRCULATION. 96:2837-2841. Author weblink.
  • Webb CM; Rosano GMC; Collins P. (21 Oct 1997). Chronic estrogen therapy improves exercise time to myocardial ischemia in postmenopausal women with coronary artery disease. CIRCULATION. 96:1731-1731. Author weblink.
  • Beale CM; Rosano GMC; Collins P. (1 Feb 1997). Chronic estrogen therapy improves exercise time to myocardial ischemia in postmenopausal women with coronary artery disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 29:7475-7475. Author weblink.
  • Beale CM; Rosano GMC; Sontag G; Collins P. (1 Feb 1997). Effect of testosterone on coronary blood flow velocity to acetylcholine in men with coronary artery disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 29:7856-7856. Author weblink.
  • Beale CM; Rosano GM; Collins P. (1 Jan 1997). Testosterone induces coronary artery dilation in men with coronary artery disease. FERTILITY AND STERILITY. O019-O019. Author weblink.
  • Rosano GM; Peters NS; Lefroy D; Lindsay DC; Sarrel PM; Collins P; Poole-Wilson PA. (15 Nov 1996). 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol. 28:1500-1505.
  • Beale CM; Collins P. (Sep 1996). The menopause and the cardiovascular system. Baillieres Clin Obstet Gynaecol. 10:483-513.
  • Rosano GM; Kaski JC; Arie S; Pereira WI; Horta P; Collins P; Pileggi F; Poole-Wilson PA. (Aug 1996). Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J. 17:1175-1180.
  • Collins P; Beale CM; Rosano GM. (Aug 1996). Oestrogen as a calcium channel blocker. Eur Heart J. 17 Suppl D:27-31.
  • Collins P. (1 Aug 1996). Women and cardiovascular disease: The cardioprotective effects of ovarian hormones - Proceedings of a Symposium held on 25 August 1995 in Amsterdam, The Netherlands - Foreword. EUROPEAN HEART JOURNAL. 17:1-1. Author weblink.
  • Ponikowski P; Rosano GM; Amadi AA; Collins P; Coats AJ; Poole-Wilson PA; Kaski JC. (1 May 1996). Transient autonomic dysfunction precedes ST-segment depression in patients with syndrome X. Am J Cardiol. 77:942-947.
  • Collins P. (Mar 1996). Vascular aspects of oestrogen. Maturitas. 23:217-226.
  • Collins P. (1996). Estrogen and cardiovascular dynamics. Am J Sports Med. 24:S30-S32.
  • Volterrani M; Rosano G; Coats A; Beale C; Collins P. (Aug 1995). Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med. 99:119-122.
  • Collins P; Rosano GM; Sarrel PM; Ulrich L; Adamopoulos S; Beale CM; McNeill JG; Poole-Wilson PA. (1 Jul 1995). 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:24-30.
  • Chester AH; Jiang C; Borland JA; Yacoub MH; Collins P. (May 1995). Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron Artery Dis. 6:417-422.
  • ROSANO GMC; COLLINS P; KASKI JC; LINDSAY DC; SARREL PM; POOLEWILSON PA. (1 May 1995). SYNDROME-X IN WOMEN IS ASSOCIATED WITH ESTROGEN DEFICIENCY. EUROPEAN HEART JOURNAL. 16:610-614.
  • KASKI JC; ROSANO GMC; COLLINS P; NIHOYANNOPOULOS P; MASERI A; POOLEWILSON PA. (15 Mar 1995). CARDIAC SYNDROME-X - CLINICAL CHARACTERISTICS AND LEFT-VENTRICULAR FUNCTION - LONG-TERM FOLLOW-UP-STUDY. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 25:807-814. Author weblink DOI.
  • Yue P; Chatterjee K; Beale C; Poole-Wilson PA; Collins P. (15 Feb 1995). Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 91:1154-1160.
  • Proudler AJ; Crook D; Godsland IF; Collins P; Rosano GM; Stevenson JC. (Feb 1995). Serum angiotensin-I-converting enzyme activity in women with cardiological syndrome X: relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart disease. J Clin Endocrinol Metab. 80:696-699.
  • Holdright DR; Hunt BJ; Parratt R; Segal H; Clarke D; Taggart D; Bennett G; Collins P. (1995). The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor. Eur J Cardiothorac Surg. 9:18-21.
  • Holdright DR; Clarke D; Fox K; Poole-Wilson PA; Collins P. (Nov 1994). The effects of intracoronary substance P and acetylcholine on coronary blood flow in patients with idiopathic dilated cardiomyopathy. Eur Heart J. 15:1537-1544.
  • SRISKANDAN S; OBRIEN MER; SMITH IE; COLLINS P; GORE ME. (1 Oct 1994). AGGRESSIVE MANAGEMENT OF DOXORUBICIN-INDUCED CARDIOMYOPATHY ASSOCIATED WITH LOW-DOSES OF DOXORUBICIN. POSTGRADUATE MEDICAL JOURNAL. 70:759-761. Author weblink.
  • Rosano GM; Ponikowski P; Adamopoulos S; Collins P; Poole-Wilson PA; Coats AJ; Kaski JC. (15 Jun 1994). Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol. 73:1174-1179.
  • Holdright DR; Lindsay DC; Clarke D; Fox K; Poole-Wilson PA; Collins P. (Dec 1993). Coronary flow reserve in patients with chest pain and normal coronary arteries. Br Heart J. 70:513-519.
  • Rosano GM; Sarrel PM; Poole-Wilson PA; Collins P. (17 Jul 1993). Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 342:133-136.
  • Holdright DR; Clarke D; Poole-Wilson PA; Fox K; Collins P. (Jul 1993). Endothelium dependent and independent responses in coronary artery disease measured at angioplasty. Br Heart J. 70:35-42.
  • Collins P; Rosano GM; Jiang C; Lindsay D; Sarrel PM; Poole-Wilson PA. (15 May 1993). Cardiovascular protection by oestrogen--a calcium antagonist effect?. Lancet. 341:1264-1265.
  • COLLINS P. (1 Apr 1993). CORONARY FLOW RESERVE. BRITISH HEART JOURNAL. 69:279-281. Author weblink.
  • Collins P; Burman J; Chung HI; Fox K. (Jan 1993). Hemoglobin inhibits endothelium-dependent relaxation to acetylcholine in human coronary arteries in vivo. Circulation. 87:80-85.
  • Jiang C; Poole-Wilson PA; Sarrel PM; Mochizuki S; Collins P; MacLeod KT. (Jul 1992). Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol. 106:739-745.
  • Lindsay DC; Jiang C; Brunotte F; Adamopoulos S; Coats AJ; Rajagopalan B; Poole-Wilson PA; Collins P. (Jul 1992). Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. Cardiovasc Res. 26:694-697.
  • COLLINS P. (1 Jul 1992). ROLE OF ENDOTHELIAL DYSFUNCTION AND ESTROGENS IN SYNDROME-X. CORONARY ARTERY DISEASE. 3:593-598. Author weblink DOI.
  • Collins P; Fox K. (Apr 1992). The pathogenesis of atheroma and the rationale for its treatment. Eur Heart J. 13:560-565.
  • Jiang CW; Sarrel PM; Lindsay DC; Poole-Wilson PA; Collins P. (11 Feb 1992). Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur J Pharmacol. 211:163-167.
  • Jiang CW; Sarrel PM; Lindsay DC; Poole-Wilson PA; Collins P. (Dec 1991). Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br J Pharmacol. 104:1033-1037.
  • Jiang CW; Poole-Wilson PA; Collins P. (Nov 1991). Comparison of rabbit coronary arterial relaxation induced by acetylcholine and lemakalim: activation of ATP sensitive potassium channels. Cardiovasc Res. 25:930-935.
  • Sarrel PM; Lindsay DC; Poole-Wilson PA; Collins P. (27 Oct 1990). Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet. 336:1030-1032.

Books

  • Wenger NK; Collins P. Wenger NK (ed); Collins P (ed). Women and Heart Disease. Second:1-640. Taylor & Francis, United Kingdom (2005).

Chapters in books

  • Webb CM; Collins P. Androgens and arterial disease. In Textbooks of men's health. 360-364. (2002).

Conferences

  • Vitale C; Collins P; Marazzi G; Caminiti G; Lodhi I; Rodenberg CA; Rosano GM. Cardiovascular Effects of Transdermal Testosterone in Postmenopausal Women. 81st Annual Scientific Session of the American-Heart-Association, 8 Nov 2008 - 12 Nov 2008. 118:S1137-S1138. LIPPINCOTT WILLIAMS & WILKINS (28 Oct 2008). Author weblink.
  • Mosca L; Grady D; Barrett-Connor E; Collins P; Wenger N; Geiger MJ; Amewou-Atisso M; Lilly E; et alKornitzer M. Risk of stroke in the raloxifene use for the heart (RUTH) trial. 79th Annual Scientific Session of the American-Heart-Association. 114:444-444. (31 Oct 2006).
  • Asbury EA; Slattery C; Grant A; Evans L; Barbir M; Collins P. Cardiac rehabilitation as a treatment for psychological morbidity, symptom severity, and cardiovascular risk factors in women with Cardiac Syndrome X. 77th Scientific Meeting of the American-Heart-Association. 110:830-830. (26 Oct 2004).
  • Elkington AG; Webb CM; Gatehouse PD; Firmin DN; Pennell DJ; Collins P. Chronic testosterone treatment in men with coronary artery disease: A study with perfusion cardiovascular magnetic resonance. 77th Scientific Meeting of the American-Heart-Association. 110:573-573. (26 Oct 2004).
  • Collins P. Cardiovascular disease - The European view. 14th Annual Meeting of the North-American-Menopause-Society. 10:564-564. (Nov 2003).
  • Khan N; DeSouza A; Flather M; Wahrborg P; Clague J; Collins P; Davies S; Sigwart U; et alPepper J. A randomised comparison of clinical outcomes, graft patency, and neuropsychological function in patients undergoing coronary artery surgery with and without cardiopulmonary bypass. Annual Scientific Conference of the British-Cardiac-Society. 89:A51-A51. (May 2003).
  • Liew R; Stagg M; MacLeod KT; Collins P. Raloxifene acutely suppresses ventricular myocyte Contractility through inhibition of the l-type calcium current. 52nd Annual Scientific Session of the American-College-of-Cardiology. 41:254A-254A. (19 Mar 2003).
  • Collins P. Sex steroids and the cardiovascular system in vivo: actions in humans. Workshop on Hormone Replacement Therapy and Cardiovascular Disease. 107-115. (2001).
  • Collins P. The effect of estrogen on the coronary vasculature. 1st International Symposium on Estrogens and the Cardiovascular Systems. 21-31. (1999).
  • Rosano GMC; Chierchia SL; Leonardo F; Beale CM; Collins P. Cardioprotective effects of ovarian hormones. Symposium on Women and Cardiovascular Disease - The Cardioprotective Effects of Ovarian Hormones. 17:15-19. (Aug 1996).
  • Collins P. Hormone replacement therapy and syndrome X. 6th Novo-Nordisk International Symposium on Postmenopausal Women - HRT Today and Into the Future. 103:68-71. (May 1996).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook